Crebinostat

CAS No. 1092061-61-4

Crebinostat ( Crebinostat )

Catalog No. M10345 CAS No. 1092061-61-4

Crebinostat is a novel cognitive enhancer that inhibits class I HDAC/1/2/3.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 745 In Stock
10MG 1017 In Stock
25MG 1431 In Stock
50MG 1782 In Stock
100MG 2250 In Stock
500MG 4410 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Crebinostat
  • Note
    Research use only, not for human use.
  • Brief Description
    Crebinostat is a novel cognitive enhancer that inhibits class I HDAC/1/2/3.
  • Description
    Crebinostat is a novel cognitive enhancer that inhibits class I HDAC/1/2/3 (IC50=0.7/1.0/2.0 nM), class IIb HDAC6 (IC50=9.3 nM) with weaker inhibition of the class I HDAC8 and no significant inhibition of the class IIa HDAC/4/5/7/9; potently induces acetylation of both histone H3 and histone H4 as well as enhanced the expression of the CREB target gene Egr1 in cultured mouse primary neurons; upregulates Bdnf and Grn, and downregulates Mapt (tau) gene expression-genes; brain penetrant.
  • Synonyms
    Crebinostat
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    HDAC
  • Recptor
    HDAC
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1092061-61-4
  • Formula Weight
    353.42
  • Molecular Formula
    C20H23N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(NO)CCCCCC(N/N=C/C1=CC=C(C2=CC=CC=C2)C=C1)=O
  • Chemical Name
    Heptanoic acid,7-(hydroxyamino)-7-oxo-,2-([1,1'-biphenyl]-4-ylmethylene)hydrazide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Fass DM, et al. Neuropharmacology. 2013 Jan;64:81-96.
2. Ghosh B, et al. Bioorg Med Chem Lett. 2016 Feb 15;26(4):1265-71.
molnova catalog
related products
  • CI-994

    A potent, selective class I HDAC inhibitor with IC50 of 0.9/0.9/1.2 uM for HDAC1/2/3, respectively.

  • RGFP 966

    RGFP966 is an HDAC3 inhibitor with IC50 of 0.08 μM in cell-free assay, exhibits > 200-fold selectivity over other HDAC.

  • SALL4 peptide FFW

    SALL4 peptide FFW (RRKFAKFQWI, FFW peptide) is a potent therapeutic SALL4 peptide antagonist of SALL4-NURD.